NCT02562196

Brief Summary

The aim of this study is to evaluate an optimized protocol of tDCS that normalize the lack of habituation and efficiency of inhibitory cortical circuits in migraine patients. For this purpose, migraineurs volunteers will undergo to optimized tDCS protocol or sham tDCS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
14

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 29, 2015

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

May 11, 2016

Status Verified

May 1, 2016

Enrollment Period

5 months

First QC Date

September 22, 2015

Last Update Submit

May 10, 2016

Conditions

Keywords

migraine disorderstranscranial direct current stimulationelectric stimulation therapypain

Outcome Measures

Primary Outcomes (1)

  • Change in headache diary variables

    it will be evaluated the number of migraine attacks, pain intensity, duration of each attack and number of painkillers intake. Patients will answer this diary during all experimental period (months).

    3 followed months

Secondary Outcomes (7)

  • Changes on Visual Evoked Potentials measures

    at baseline, 1 month and 2 months, 3 months

  • Changes on HIT-6

    at baseline, 1 month and 2 months, 3 months.

  • Changes on MIDAS

    at baseline, 1 month and 2 months, 3 months.

  • Changes on VAS

    at baseline, 1 month and 2 months, 3 months.

  • Changes on motor evoked potentials

    through study completion, assessed up to 1 month (before and after each section)

  • +2 more secondary outcomes

Study Arms (2)

optimized protocol chosen

EXPERIMENTAL

a randomized, sham-controlled, double-blinded and parallel group trial (12 therapeutic sessions) with optimal protocol (defined in phase 1) and sham tDCS will be conducted to evaluated electrical cortical activity and pain control, number of migraine attacks and quality of life of migraine patients. An interval of 48hs between sessions will be taken.

Device: tdcs

sham tDCS

SHAM COMPARATOR

a randomized, sham-controlled, double-blinded and parallel group trial (12 therapeutic sessions) with optimal protocol (defined in phase 1) and sham tDCS will be conducted to evaluated electrical cortical activity and pain control, number of migraine attacks and quality of life of migraine patients. An interval of 48hs between sessions will be taken.

Device: tdcs

Interventions

tdcsDEVICE

The direct electric current will be applied by surface electrodes with 35cm² and composed of rubbers conductive electricity and surrounded by sponges soaked in saline solution. The electrodes position will be performed according the 10-20 international system of marking and the different montages will be realized by distinct applications sites. To stimuli the primary motor cortex the active electrode will be positioned on C3 point and the reference electrode on the contralateral supraorbital region. To visual cortex stimulation, the active electrode will be positioned on the Oz point and the reference on Cz. To duo stimulation, the two electrodes will be considerate actives, stimulating the visual and motor cortex simultaneously. The sham tDCS has already been used in several studies to assess the effect active tDCS and the duration of the current is only 30 seconds.

optimized protocol chosensham tDCS

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Presented diagnostic of episodic migraine with or without aura or probably migraine with or without aura according to the criteria for diagnosis of International Classification of Headache Disorders (ICHD-III)
  • Disease duration of at least 12 months
  • Without preventive medication for at least 6 months prior to initiation of treatment

You may not qualify if:

  • Pregnant women;
  • Pacemaker;
  • History of seizures;
  • Metallic implants in the head;
  • Patients with clinical evidence of brain injuries;
  • Chronic pain associated to others diseases;
  • Use of neuroleptic medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Neuroscience Laboratory

Recife, Pernambuco, Brazil

RECRUITING

MeSH Terms

Conditions

Migraine DisordersPain

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Kátia Monte-Silva, PhD

    Universidade Federal de Pernambuco

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kátia Monte-Silva, PhD

CONTACT

Sérgio Rocha, MsC

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Effect of Transcranial Direct Current Stimulation (tDCS) Optimized Protocol for the Treatment of Migraine

Study Record Dates

First Submitted

September 22, 2015

First Posted

September 29, 2015

Study Start

March 1, 2016

Primary Completion

August 1, 2016

Study Completion

April 1, 2018

Last Updated

May 11, 2016

Record last verified: 2016-05

Locations